Restoration of motor inhibition through an abnormal premotor-motor connection in dystonia.
Identifieur interne : 001884 ( PubMed/Corpus ); précédent : 001883; suivant : 001885Restoration of motor inhibition through an abnormal premotor-motor connection in dystonia.
Auteurs : Ying-Zu Huang ; John C. Rothwell ; Chin-Song Lu ; Jiunjie Wang ; Rou-Shayn ChenSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2010.
English descriptors
- KwdEn :
- Adult, Analysis of Variance, Biophysics, Dystonia (genetics), Dystonia (pathology), Dystonia (therapy), Dystonic Disorders (pathology), Dystonic Disorders (therapy), Electric Stimulation (methods), Electromyography (methods), Evoked Potentials, Motor (physiology), Female, Hand (innervation), Humans, Male, Middle Aged, Molecular Chaperones (genetics), Motor Cortex (physiopathology), Neural Inhibition (physiology), Transcranial Magnetic Stimulation, Treatment Outcome, Writing.
- MESH :
- chemical , genetics : Molecular Chaperones.
- genetics : Dystonia.
- innervation : Hand.
- methods : Electric Stimulation, Electromyography.
- pathology : Dystonia, Dystonic Disorders.
- physiology : Evoked Potentials, Motor, Neural Inhibition.
- physiopathology : Motor Cortex.
- therapy : Dystonia, Dystonic Disorders.
- Adult, Analysis of Variance, Biophysics, Female, Humans, Male, Middle Aged, Transcranial Magnetic Stimulation, Treatment Outcome, Writing.
Abstract
To clarify the rationale for using rTMS of dorsal premotor cortex (PMd) to treat dystonia, we examined how the motor system reacts to an inhibitory form of rTMS applied to the PMd in healthy subjects and in a group of patients with focal hand dystonia and DYT1 gene carriers. Continuous theta burst transcranial magnetic stimulation (cTBS) with 300 and 600 pulses (cTBS300 and cTBS600) was applied to PMd, and its after-effects were quantified by measuring the amplitude of MEPs evoked by single pulse transcranial magnetic stimulation (TMS) over the primary motor cortex (M1), short interval intracortical inhibition/facilitation (SICI/ICF) within M1, the third phase of spinal reciprocal inhibition (RI), and writing tests. In addition, in DYT1 gene carriers, the effects of cTBS300 over M1 and PMd on MEPs were studied in separate experiments. In healthy subjects, cTBS300 and cTBS600 over PMd suppressed MEPs for 30 min or more and cTBS600 decreased SICI and RI. In contrast, neither form of cTBS over PMd had any significant effect on MEPs, while cTBS600 increased effectiveness of SICI and RI and improved writing in patients with writer's cramp. NMDYT1 had a normal response to cTBS300 over left PMd. We suggest that the reduced PMd to M1 interaction in dystonic patients is likely to be due to reduced excitability of PMd-M1 connections. The possible therapeutic effects of premotor rTMS may therefore involve indirect effects of PMd on SICI and RI, which this study has shown can be normalised by cTBS.
DOI: 10.1002/mds.22814
PubMed: 20309999
Links to Exploration step
pubmed:20309999Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Restoration of motor inhibition through an abnormal premotor-motor connection in dystonia.</title>
<author><name sortKey="Huang, Ying Zu" sort="Huang, Ying Zu" uniqKey="Huang Y" first="Ying-Zu" last="Huang">Ying-Zu Huang</name>
<affiliation><nlm:affiliation>Department of Neurology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rothwell, John C" sort="Rothwell, John C" uniqKey="Rothwell J" first="John C" last="Rothwell">John C. Rothwell</name>
</author>
<author><name sortKey="Lu, Chin Song" sort="Lu, Chin Song" uniqKey="Lu C" first="Chin-Song" last="Lu">Chin-Song Lu</name>
</author>
<author><name sortKey="Wang, Jiunjie" sort="Wang, Jiunjie" uniqKey="Wang J" first="Jiunjie" last="Wang">Jiunjie Wang</name>
</author>
<author><name sortKey="Chen, Rou Shayn" sort="Chen, Rou Shayn" uniqKey="Chen R" first="Rou-Shayn" last="Chen">Rou-Shayn Chen</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="doi">10.1002/mds.22814</idno>
<idno type="RBID">pubmed:20309999</idno>
<idno type="pmid">20309999</idno>
<idno type="wicri:Area/PubMed/Corpus">001884</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Restoration of motor inhibition through an abnormal premotor-motor connection in dystonia.</title>
<author><name sortKey="Huang, Ying Zu" sort="Huang, Ying Zu" uniqKey="Huang Y" first="Ying-Zu" last="Huang">Ying-Zu Huang</name>
<affiliation><nlm:affiliation>Department of Neurology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rothwell, John C" sort="Rothwell, John C" uniqKey="Rothwell J" first="John C" last="Rothwell">John C. Rothwell</name>
</author>
<author><name sortKey="Lu, Chin Song" sort="Lu, Chin Song" uniqKey="Lu C" first="Chin-Song" last="Lu">Chin-Song Lu</name>
</author>
<author><name sortKey="Wang, Jiunjie" sort="Wang, Jiunjie" uniqKey="Wang J" first="Jiunjie" last="Wang">Jiunjie Wang</name>
</author>
<author><name sortKey="Chen, Rou Shayn" sort="Chen, Rou Shayn" uniqKey="Chen R" first="Rou-Shayn" last="Chen">Rou-Shayn Chen</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Analysis of Variance</term>
<term>Biophysics</term>
<term>Dystonia (genetics)</term>
<term>Dystonia (pathology)</term>
<term>Dystonia (therapy)</term>
<term>Dystonic Disorders (pathology)</term>
<term>Dystonic Disorders (therapy)</term>
<term>Electric Stimulation (methods)</term>
<term>Electromyography (methods)</term>
<term>Evoked Potentials, Motor (physiology)</term>
<term>Female</term>
<term>Hand (innervation)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Molecular Chaperones (genetics)</term>
<term>Motor Cortex (physiopathology)</term>
<term>Neural Inhibition (physiology)</term>
<term>Transcranial Magnetic Stimulation</term>
<term>Treatment Outcome</term>
<term>Writing</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Molecular Chaperones</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Dystonia</term>
</keywords>
<keywords scheme="MESH" qualifier="innervation" xml:lang="en"><term>Hand</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Electric Stimulation</term>
<term>Electromyography</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Dystonia</term>
<term>Dystonic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Evoked Potentials, Motor</term>
<term>Neural Inhibition</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Motor Cortex</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Dystonia</term>
<term>Dystonic Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Analysis of Variance</term>
<term>Biophysics</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Transcranial Magnetic Stimulation</term>
<term>Treatment Outcome</term>
<term>Writing</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To clarify the rationale for using rTMS of dorsal premotor cortex (PMd) to treat dystonia, we examined how the motor system reacts to an inhibitory form of rTMS applied to the PMd in healthy subjects and in a group of patients with focal hand dystonia and DYT1 gene carriers. Continuous theta burst transcranial magnetic stimulation (cTBS) with 300 and 600 pulses (cTBS300 and cTBS600) was applied to PMd, and its after-effects were quantified by measuring the amplitude of MEPs evoked by single pulse transcranial magnetic stimulation (TMS) over the primary motor cortex (M1), short interval intracortical inhibition/facilitation (SICI/ICF) within M1, the third phase of spinal reciprocal inhibition (RI), and writing tests. In addition, in DYT1 gene carriers, the effects of cTBS300 over M1 and PMd on MEPs were studied in separate experiments. In healthy subjects, cTBS300 and cTBS600 over PMd suppressed MEPs for 30 min or more and cTBS600 decreased SICI and RI. In contrast, neither form of cTBS over PMd had any significant effect on MEPs, while cTBS600 increased effectiveness of SICI and RI and improved writing in patients with writer's cramp. NMDYT1 had a normal response to cTBS300 over left PMd. We suggest that the reduced PMd to M1 interaction in dystonic patients is likely to be due to reduced excitability of PMd-M1 connections. The possible therapeutic effects of premotor rTMS may therefore involve indirect effects of PMd on SICI and RI, which this study has shown can be normalised by cTBS.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">20309999</PMID>
<DateCreated><Year>2010</Year>
<Month>05</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted><Year>2010</Year>
<Month>07</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>08</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>25</Volume>
<Issue>6</Issue>
<PubDate><Year>2010</Year>
<Month>Apr</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Restoration of motor inhibition through an abnormal premotor-motor connection in dystonia.</ArticleTitle>
<Pagination><MedlinePgn>696-703</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.22814</ELocationID>
<Abstract><AbstractText>To clarify the rationale for using rTMS of dorsal premotor cortex (PMd) to treat dystonia, we examined how the motor system reacts to an inhibitory form of rTMS applied to the PMd in healthy subjects and in a group of patients with focal hand dystonia and DYT1 gene carriers. Continuous theta burst transcranial magnetic stimulation (cTBS) with 300 and 600 pulses (cTBS300 and cTBS600) was applied to PMd, and its after-effects were quantified by measuring the amplitude of MEPs evoked by single pulse transcranial magnetic stimulation (TMS) over the primary motor cortex (M1), short interval intracortical inhibition/facilitation (SICI/ICF) within M1, the third phase of spinal reciprocal inhibition (RI), and writing tests. In addition, in DYT1 gene carriers, the effects of cTBS300 over M1 and PMd on MEPs were studied in separate experiments. In healthy subjects, cTBS300 and cTBS600 over PMd suppressed MEPs for 30 min or more and cTBS600 decreased SICI and RI. In contrast, neither form of cTBS over PMd had any significant effect on MEPs, while cTBS600 increased effectiveness of SICI and RI and improved writing in patients with writer's cramp. NMDYT1 had a normal response to cTBS300 over left PMd. We suggest that the reduced PMd to M1 interaction in dystonic patients is likely to be due to reduced excitability of PMd-M1 connections. The possible therapeutic effects of premotor rTMS may therefore involve indirect effects of PMd on SICI and RI, which this study has shown can be normalised by cTBS.</AbstractText>
<CopyrightInformation>2010 Movement Disorder Society</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Ying-Zu</ForeName>
<Initials>YZ</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rothwell</LastName>
<ForeName>John C</ForeName>
<Initials>JC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lu</LastName>
<ForeName>Chin-Song</ForeName>
<Initials>CS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>JiunJie</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chen</LastName>
<ForeName>Rou-Shayn</ForeName>
<Initials>RS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>G0500258</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018832">Molecular Chaperones</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C108175">TOR1A protein, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1993 Jan;43(1):183-5</RefSource>
<PMID Version="1">8423882</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurophysiol Clin. 2004 Oct;34(3-4):141-5</RefSource>
<PMID Version="1">15501683</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 1995 Mar;37(3):363-72</RefSource>
<PMID Version="1">7695236</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurology. 1995 Sep;45(9):1671-7</RefSource>
<PMID Version="1">7675225</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurology. 1996 May;46(5):1371-6</RefSource>
<PMID Version="1">8628484</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Psychol. 1964 May;55:219-25</RefSource>
<PMID Version="1">14168486</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Physiol. 2004 Nov 15;561(Pt 1):331-8</RefSource>
<PMID Version="1">15459244</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Brain. 2005 Jan;128(Pt 1):104-15</RefSource>
<PMID Version="1">15483042</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuron. 2005 Jan 20;45(2):201-6</RefSource>
<PMID Version="1">15664172</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2006 Jan;12(1):15-9</RefSource>
<PMID Version="1">16198613</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Physiol. 2006 May 1;572(Pt 3):857-68</RefSource>
<PMID Version="1">16497712</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2006 Dec;21(12):2181-6</RefSource>
<PMID Version="1">17078060</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arq Neuropsiquiatr. 2007 Sep;65(3A):697-9</RefSource>
<PMID Version="1">17876418</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cereb Cortex. 2008 Mar;18(3):563-70</RefSource>
<PMID Version="1">17573373</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2008 Apr 15;23(5):660-8</RefSource>
<PMID Version="1">18175342</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Restor Neurol Neurosci. 2009;27(1):55-65</RefSource>
<PMID Version="1">19164853</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurophysiol Clin. 2009 Feb;39(1):27-30</RefSource>
<PMID Version="1">19268844</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Neurophysiol. 2009 Apr;120(4):796-801</RefSource>
<PMID Version="1">19231274</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Brain Stimul. 2009 Jan;2(1):2-13</RefSource>
<PMID Version="1">20633398</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurology. 2001 Aug 14;57(3):449-55</RefSource>
<PMID Version="1">11502912</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuroimage. 2001 Dec;14(6):1444-53</RefSource>
<PMID Version="1">11707100</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2002 Jan 15;22(2):554-61</RefSource>
<PMID Version="1">11784802</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Brain. 2003 Sep;126(Pt 9):2074-80</RefSource>
<PMID Version="1">12821514</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Brain. 2003 Dec;126(Pt 12):2710-25</RefSource>
<PMID Version="1">12937071</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Physiol. 2004 Jan 15;554(Pt 2):483-95</RefSource>
<PMID Version="1">14555728</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2004 Jan;19(1):54-9</RefSource>
<PMID Version="1">14743361</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Physiol. 1993 Nov;471:501-19</RefSource>
<PMID Version="1">8120818</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000704">Analysis of Variance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001703">Biophysics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004421">Dystonia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D020821">Dystonic Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004558">Electric Stimulation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004576">Electromyography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D019054">Evoked Potentials, Motor</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006225">Hand</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000294">innervation</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018832">Molecular Chaperones</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009044">Motor Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009433">Neural Inhibition</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D050781">Transcranial Magnetic Stimulation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D014956">Writing</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC3000921</OtherID>
<OtherID Source="NLM">UKMS33589</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>3</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>3</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>7</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.22814</ArticleId>
<ArticleId IdType="pubmed">20309999</ArticleId>
<ArticleId IdType="pmc">PMC3000921</ArticleId>
<ArticleId IdType="mid">UKMS33589</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001884 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001884 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:20309999 |texte= Restoration of motor inhibition through an abnormal premotor-motor connection in dystonia. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:20309999" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |